Monitoring of inosine monophosphate dehydrogenase activity in mononuclear cells of children with acute lymphoblastic leukemia: Enzymological and clinical aspects
Pediatric Blood & Cancer2005Vol. 46(4), pp. 434–438
Citations Over Time
C. Brouwer, Diana G.M. Vermunt‐de Koning, Robert C. Trueworthy, Patricia G.J.H. ter Riet, John A. Duley, Frans J.M. Trijbels, Peter M. Hoogerbrugge, Jos P.M. Bökkerink, Elisabeth R. van Wering, Ronney A. De Abreu
Abstract
The decrease of IMPDH activity at remission of ALL seems to be at least partly due to the eradication of lymphoblasts with the type 2 isoform of the enzyme.
Related Papers
- → Analysis of ATP and Its Breakdown Products in Beef by Reversed‐Phase HPLC(1989)49 cited
- → Sensory Changes in Umami Taste of Inosine 5′‐Monophosphate Solution after Heating(1991)42 cited
- → INOSINE MONOPHOSPHATE (IMP) AND HYPOXANTHINE FORMATION IN THREE SPECIES OF SHRIMP HELD ON ICE(1971)14 cited
- → The amination of inosine monophosphate in skeletal muscle(1961)28 cited
- Towards personalized medicine: Utilizing biomarkers to track response of the inosine monophosphate dehydrogenase (IMPDH) inhibitor AVN944 patient samples from a Phase I clinical trial in AML and evaluation of a patient stratification signature.(2007)